Pancreatic adenocarcinoma: Clinical practice guidelines in oncology

Margaret A. Tempero, J. Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B. Benson, Jordan D. Berlin, John L. Cameron, Ephraim S. Casper, Steven J. Cohen, Michelle Duff, Joshua D.I. Ellenhorn, William G. Hawkins, John P. Hoffman, Boris W. Kuvshinoff, Mokenge P. Malafa, Peter Muscarella, Eric K. Nakakura, Aaron R. Sasson, Sarah P. Thayer, Douglas S. TylerRobert S. Warren, Samuel Whiting, Christopher Willett, Robert A. Wolff

Research output: Contribution to journalReview article

120 Scopus citations

Abstract

Overall, in view of the relatively high likelihood of a poor outcome for patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

Original languageEnglish (US)
Pages (from-to)972-973+991-1016
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number9
Publication statusPublished - Sep 1 2010
Externally publishedYes

    Fingerprint

Keywords

  • Adenocarcinoma
  • Ductal carcinoma
  • Endoscopic retrograde cholangiopancreatography
  • Gemcitabine
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Pancreas
  • Ultrasonography

ASJC Scopus subject areas

  • Oncology

Cite this

Tempero, M. A., Arnoletti, J. P., Behrman, S., Ben-Josef, E., Benson, A. B., Berlin, J. D., ... Wolff, R. A. (2010). Pancreatic adenocarcinoma: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 8(9), 972-973+991-1016.